ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio Market Cap : 46.98M for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 46.98M |
| November 04, 2026 | 46.24M |
| November 03, 2026 | 45.34M |
| November 02, 2026 | 46.13M |
| October 30, 2026 | 46.24M |
| October 29, 2026 | 45.68M |
| October 28, 2026 | 47.37M |
| October 27, 2026 | 45.34M |
| October 26, 2026 | 45.68M |
| October 23, 2026 | 47.60M |
| October 22, 2026 | 45.62M |
| October 21, 2026 | 46.08M |
| October 20, 2026 | 46.58M |
| October 19, 2026 | 45.12M |
| October 16, 2026 | 45.57M |
| October 15, 2026 | 45.45M |
| October 14, 2026 | 46.81M |
| October 13, 2026 | 47.82M |
| October 12, 2026 | 47.94M |
| October 09, 2026 | 47.82M |
| October 08, 2026 | 48.05M |
| October 07, 2026 | 52.00M |
| October 06, 2026 | 51.88M |
| October 05, 2026 | 53.01M |
| October 02, 2026 | 51.88M |
| Date | Value |
|---|---|
| October 01, 2026 | 51.66M |
| September 30, 2026 | 51.66M |
| September 29, 2026 | 51.66M |
| September 28, 2026 | 52.34M |
| September 25, 2026 | 53.24M |
| September 24, 2026 | 52.56M |
| September 23, 2026 | 54.59M |
| September 22, 2026 | 54.70M |
| September 21, 2026 | 54.25M |
| September 18, 2026 | 55.15M |
| September 17, 2026 | 56.62M |
| September 16, 2026 | 55.61M |
| September 15, 2026 | 55.49M |
| September 14, 2026 | 56.40M |
| September 11, 2026 | 57.30M |
| September 10, 2026 | 56.45M |
| September 09, 2026 | 56.51M |
| September 08, 2026 | 56.96M |
| September 04, 2026 | 54.70M |
| September 03, 2026 | 55.10M |
| September 02, 2026 | 55.94M |
| September 01, 2026 | 56.62M |
| August 31, 2026 | 57.52M |
| August 28, 2026 | 60.23M |
| August 27, 2026 | 60.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.596B |
| Alnylam Pharmaceuticals, Inc. | 21.05B |
| Anika Therapeutics, Inc. | 226.84M |
| Savara, Inc. | 934.57M |
| Vericel Corp. | 2.607B |
Market Cap Related Metrics
| Price to Book Value | 0.3307 |
| Price | 4.165 |
| Earnings Yield | -124.8% |